Old Web
English
Sign In
Acemap
>
authorDetail
>
Maissa Mhibik
Maissa Mhibik
National Institutes of Health
Chronic lymphocytic leukemia
Ibrutinib
T cell
Immunotherapy
Bruton's tyrosine kinase
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
BTK Inhibitors, Irrespective of ITK Inhibition, Increase Efficacy of a CD19/CD3 Bispecific Antibody in CLL.
2021
Blood
Maissa Mhibik
Erika M Gaglione
David Eik
Ellen K. Kendall
Amy Blackburn
Keyvan Keyvanfar
Maria João Baptista
Inhye E. Ahn
Clare Sun
Junpeng Qi
Christoph Rader
Adrian Wiestner
Show All
Source
Cite
Save
Citations (0)
Harnessing the Effects of BTKi on T Cells for Effective Immunotherapy against CLL
2019
International Journal of Molecular Sciences
Maissa Mhibik
Adrian Wiestner
Clare Sun
Show All
Source
Cite
Save
Citations (17)
A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib
2019
Blood
Maissa Mhibik
Erika M Gaglione
Amy Blackburn
Keyvan Keyvanfar
Clare Sun
Inhye E. Ahn
Maria-Joao Baptista
Junpeng Qi
Christoph Rader
Adrian Wiestner
Show All
Source
Cite
Save
Citations (0)
1